Clinical Trials Corner: Reimagining RADICAL

Abstract

The Clinical Trials Corner of Kidney Cancer highlights planned or ongoing high-impact studies in renal cell carcinoma (RCC). In this issue, we revisit the RADICAL trial, an important study evaluating the potential benefi t of Radium-223 therapy in RCC patients with bone metastases, which has recently been amended. In the future, attention to a specifi c trial, us metastases turnover in metastatic castration An Phase I trial of Radium-223 combined in